FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine, namely to haematology and can be used for normalising impaired haemostasis. Methods include administering a clotting factor treatment consisting of FII, PCC and a three factor combination of FII, FX and FVIIa or fibrinogen and FII.
EFFECT: use of these inventions enables to reduce the risk of thromboembolic complications.
24 cl, 12 dwg, 2 ex
Authors
Dates
2017-01-10—Published
2011-09-19—Filed